USP43 Activators
The chemical compounds identified as potential USP43 activators function through various cellular signaling pathways and processes that can indirectly enhance the activity of USP43. Forskolin, by increasing intracellular cAMP, would influence a variety of cellular processes, potentially including those involving deubiquitinating enzymes such as USP43. Similarly, IBMX raises cAMP levels, leading to activation of PKA and subsequent changes in the phosphorylation state of proteins, which could indirectly enhance USP43 activity. The inhibition of protein phosphatases by Okadaic Acid leads to increased protein phosphorylation, which could enhance USP43 activity indirectly by altering the interaction and regulation of proteins that associate with USP43. Additionally, proteasome inhibition by MG132 could lead to an accumulation of ubiquitinated proteins, increasing the substrate availability for USP43.
PI3K inhibition by LY294002 results in altered cell survival signaling, which could lead to changes in the ubiquitination patterns that USP43 could act upon, potentially enhancing its activity. Rapamycin, an mTOR inhibitor, could alter the cellular environment in response to growth signals and affect the ubiquitination landscape, which could enhance USP43 activity. MEK inhibition by U0126 and p38 MAPK inhibition by SB203580 could have similar effects by altering cell proliferation, differentiation, and stress response signaling pathways, thereby modifying the cellular context for USP43 activity. Inhibitors of the JNK pathway, such as SP600125, could also enhance USP43 activity by changing stress response
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, resulting in increased levels of cyclic AMP (cAMP) within the cell. cAMP is a second messenger important in many biological processes. USP43 can be enhanced by elevated cAMP, as cAMP can influence a broad range of cellular processes including those that may involve deubiquitinating enzymes like USP43. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which is involved in controlling the function of other proteins through the phosphorylation of hydroxyl groups of serine and threonine amino acids on these proteins. PKC activation can indirectly enhance USP43 activity by modulating the phosphorylation state of proteins that interact with or regulate USP43. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which increases intracellular cAMP levels by preventing its breakdown. Elevated cAMP can activate PKA, leading to changes in protein phosphorylation and potential enhancement of USP43 activity. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A), enzymes that remove phosphate groups from serine and threonine residues in proteins. Inhibition of these phosphatases can lead to a net increase in protein phosphorylation, potentially enhancing USP43 activity through altered protein-protein interactions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3K), affecting the PI3K/Akt pathway, which plays a key role in regulating cell survival and apoptosis. PI3K inhibition can lead to alterations in cellular signaling that indirectly enhance USP43 activity through changes in cellular stress responses and protein ubiquitination patterns. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor, directly binding to mTORC1. By inhibiting mTORC1, rapamycin can influence cellular growth and metabolism pathways, potentially enhancing USP43 activity as the cell responds to altered growth signals. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, affecting inflammatory response and stress-induced signaling. Inhibition of p38 MAPK can alter cellular responses to stress and inflammation, potentially enhancing USP43 activity through changes in the ubiquitination landscape that USP43 could act upon. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, modulating the JNK signaling pathway, which is involved in stress responses, apoptosis, and cellular differentiation. JNK inhibition can lead to changes that enhance USP43 activity by altering the stress response pathways and ubiquitination processes within the cell. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that leads to an increase in the cellular levels of ubiquitinated proteins by preventing their degradation. This accumulation can indirectly enhance USP43 activity by increasing the substrate availability for deubiquitination. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an inhibitor of histone deacetylases (HDACs), which leads to changes in chromatin structure and gene expression. This can indirectly enhance USP43 activity by altering the expression patterns of proteins that regulate or interact with USIt is important to note that as of my last update in September 2021, there may not be well-characterized direct activators for USP43, and the following table is based on hypothetical reasoning about the biology of the protein and related pathways: | ||||||